Skip to main content
. 2019 Jul 2;104(11):5611–5620. doi: 10.1210/jc.2019-00924

Figure 3.

Figure 3.

Sensitivity analyses for the BMD increase differences between denosumab and teriparatide. Effect-size estimates from sensitivity analyses were consistent with the primary analysis at all the three sites (the lumbar spine, total hip, and femoral neck). PS, propensity score.